This series on “Multidisciplinary Treatment in Gastrointestinal Cancer” is edited by Prof. Paolo Mercantini, Sant’Andrea Hospital, Sapienza University of Rome, Italy. The main purposes of this series are to discuss 1) current management of gastrointestinal tumors, 2) optimal surgical management in gastrointestinal tumors, and 3) target therapy in gastrointestinal oncology.

Paolo Mercantini, MD, PhD
Sant’Andrea Hospital, Sapienza University of Rome, Italy

Prof. Paolo Mercantini received his medical degree disserting a thesis on “Non-neoplastic Portal Vein Thrombosis” in 1995 and completed a 5-year residency in General Surgery at La Sapienza University of Rome in 2000. In 2004, he obtained a PhD in General Surgery with a dissertation on “Genetic and molecular alterations in colorectal Carcinoma” at La Sapienza University of Rome - Department of Surgery Pietro Valdoni, Rome, Italy.

Prof. Paolo Mercantini is Research Staff Surgeon in General and Oncologic Surgery since 2003 and actually is an Associate Professor of Surgery at the Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Italy.

Currently, Prof. Mercantini teaches Surgery at La Sapienza University of Rome in Master degree in Medicine course, in General Surgery Residency School and in PhD in Oncology course. He is Academical Staff Surgeon at Sant’Andrea University Hospital, Department of Medical-Surgical Sciences and Translational Medicine, Rome, Italy. He experienced more than 3000 surgical procedures involving gastrointestinal, hepatobiliary and pancreatic surgery with special focus on minimally invasive technique, laparoscopic and robotic. He is skillful in the surgical treatment and multidisciplinary treatment of rectal and gastric cancer and in the diagnosis and treatment of neuroendocrine tumors.

Prof. Paolo Mercantini is author of 129 publications on national and international peer reviewed journals and oral presenter in more than 80 national and international conferences. His main area of research interest is colorectal, gastric and hepatobiliary pancreatic malignancies with a specific focus on minimal invasive surgical technique. He is active member of Italian Society of Surgical Oncology (SICO), Italian Society of Endoscopic Surgery (SICE), Italian Society of Surgery (SIC) and European Society of Neuroendocrine Tumors (ENETS).

Series outline: 

1. Multidisciplinary Treatment in Gastrointestinal Cancer
2. TRG and gastric cancer
3. Muldisciplinary Team in gastrointestinal cancer
4. Radiomics in Gastrointestinal Imaging
5. Fluorescence in gastric oncologic surgery: up to date
6. The role of ALPPS in treatment of colo-rectal liver metastasis
7. Radiotherapy in gastric cancer: does it still play a significant role?

Disclosure:
The series on “Multidisciplinary Treatment in Gastrointestinal Cancer” is commissioned by the editorial office, Digestive Medicine Research (DMR) without any sponsorship or funding. Prof. Paolo Mercantini serves as the unpaid Guest Editor for the series.